Semler ScientificSMLR
About: Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Employees: 92
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
8.05% more ownership
Funds ownership: 45.03% [Q2] → 53.08% (+8.05%) [Q3]
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
9% less funds holding
Funds holding: 91 [Q2] → 83 (-8) [Q3]
19% less capital invested
Capital invested by funds: $109M [Q2] → $88.3M (-$21.2M) [Q3]
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
Research analyst outlook
We haven’t received any recent analyst ratings for SMLR.
Financial journalist opinion
Based on 6 articles about SMLR published over the past 30 days